NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection

Laboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, Connecticut, USAand Section of Pulmonary and Critical Care Medicine, Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana, USA

Laboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, Connecticut, USAand Section of Pulmonary and Critical Care Medicine, Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana, USA

Laboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, Connecticut, USAand Section of Pulmonary and Critical Care Medicine, Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana, USA

Laboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, Connecticut, USAand Section of Pulmonary and Critical Care Medicine, Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana, USA

Laboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, Connecticut, USAand Section of Pulmonary and Critical Care Medicine, Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana, USA

Laboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, Connecticut, USAand Section of Pulmonary and Critical Care Medicine, Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana, USA

Laboratory of Lung Biology, Department of Pathobiological Sciences and Center for Experimental Infectious Disease Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, Connecticut, USAand Section of Pulmonary and Critical Care Medicine, Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana, USA